TOP TIERMARKET NEWSWIRE

News & sentiment

LANTHEUS HLDGS INC (LNTH) — News & AI sentiment

LANTHEUS HLDGS INC (LNTH) news roundup. 3 stories in the past week, 17 over 30 days. Average 30-day sentiment is 50.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

3

avg sentiment 44.7/100

30d stories

17

avg sentiment 50.5/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

LNTH news in the last 24 hours, 7 days, 30 days and 90 days

How much LNTH coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	LNTH stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	3	44.7/100	LNTH headlines →
Last 30 days	17	50.5/100	LNTH headlines →
Last 90 days	59	55.5/100	LNTH headlines →

Latest stories on LNTH

Lantheus receives FTC second request on Curium deal

Seeking Alpha42 · neutralm&a

6d ago

Lantheus Merger Review Intensifies After FTC Second Request

TipRanks42 · neutralm&a

6d ago

Lantheus Holdings, Inc. (LNTH) files 8-K

SEC 8-K50 · neutralgeneral

6d ago

Banks Vie for $4.25 Billion Debt Financing to Back Lantheus Deal

Bloomberg58 · neutralm&a

Oct 15

Lantheus Holdings, Inc. (LNTH) files 8-K

SEC 8-K50 · neutralgeneral

Oct 14

Lantheus downgraded to Neutral from Outperform at Mizuho

The Fly34 · bearishanalyst

Oct 13

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Option Care Health, Inc. (Nasdaq – OPCH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies Corporation (Nasdaq – SANG)

GlobeNewswire42 · neutralgeneral

Oct 6

Lantheus Issues Supplemental Disclosures Ahead Curium Merger Vote

TipRanks55 · neutralm&a

Oct 2

Lantheus Holdings, Inc. (LNTH) files 8-K

SEC 8-K50 · neutralgeneral

Oct 2

Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders

GlobeNewswire42 · neutralgeneral

Sep 30

$HAREHOLDER ALERT - The M&A Class Action Firm Continues to Investigate the Merger — FHB, INDV, ITGR, and LNTH

GlobeNewswire50 · neutralgeneral

Sep 30

Lantheus announces CMS granted TPT payment status for PYLARIFY TruVu injection

The Fly63 · neutralproduct/pr

Sep 30

Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)

GlobeNewswire67 · bullishproduct/pr

Sep 30

Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)

Business Insider67 · bullishproduct/pr

Sep 30

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SoundThinking, Inc. (Nasdaq – SSTI), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies Corporation (Nasdaq – SANG)

GlobeNewswire42 · neutralgeneral

Sep 29

ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH

PR Newswire42 · neutralm&a

Sep 28

Lantheus announces first patient dosed in Phase 2/3 trial of LNTH-2401

The Fly63 · neutralproduct/pr

Sep 28

Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer

GlobeNewswire63 · neutralproduct/pr

Sep 28

Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer

StockTitan63 · neutralproduct/pr

Sep 28

Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, LNTH are Obtaining Fair Deals for their Shareholders

GlobeNewswire38 · neutralgeneral

Sep 24

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

GlobeNewswire34 · bearishgeneral

Sep 24

Strong Earnings, FDA Approval, and Takeover Interest Drive Lantheus Holdings’ (LNTH) Rally

Yahoo Finance73 · bullishearnings

Sep 23

Lantheus gains approval of Bravnesta, generic competitor to Lutathera

Seeking Alpha73 · bullishproduct/pr

Sep 22

Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs

GlobeNewswire73 · bullishproduct/pr

Sep 22

Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs

StockTitan72 · bullishproduct/pr

Sep 22

Open LNTH in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →